Kleinbongard P, Baars T, Möhlenkamp S, Kahlert P, Erbel R, Heusch G. Aspirate from human stented native coronary arteries vs. saphenous vein grafts: more endothelin but less particulate debris. Am J Physiol Heart Circ Physiol 305: H1222-H1229, 2013. First published August 9, 2013; doi:10.1152/ajpheart.00358.2013.-Stent implantation into atherosclerotic coronary arteries releases particulate debris and soluble substances that contribute to impaired microvascular perfusion. Here we addressed the potential for microvascular obstruction in patients with stenotic native right coronary arteries (nRCA) compared with saphenous vein grafts on right coronary arteries (SVG-RCA). We enrolled symptomatic, male patients with stable angina pectoris and a flow-limiting stenosis in their nRCA or SVG-RCA (n ϭ 18/18). Plaque volume and composition were analyzed using intravascular ultrasound before stent implantation. Coronary aspirate was retrieved during stent implantation under protection with a distal occlusion/aspiration device and divided into particulate debris and plasma. The release of catecholamines, endothelin, serotonin, thromboxane B2, and tumor necrosis factor-␣ was measured. The response of rat mesenteric arteries with intact (ϩE) and denuded (ϪE) endothelium to aspirate plasma (without and with selective endothelin receptor blockade) was normalized to that by potassium chloride (KClmax ϭ 100%). Plaque volume and composition were not different between nRCA and SVG-RCA. There was less particulate debris (65 Ϯ 8 vs. 146 Ϯ 23 mg; P Ͻ 0.05) and more endothelin release (5.8 Ϯ 0.8 vs. 1.3 Ϯ 0.7 pg/ml; P Ͻ 0.05) in nRCA than in SVG-RCA, whereas the release of the other mediators was not different. Aspirate from nRCA induced stronger vasoconstriction than that from SVG-RCA [nRCA, 78 Ϯ 6% (ϩE)/84 Ϯ 5% (ϪE); SVG-RCA, 59 Ϯ 6% (ϩE)/68 Ϯ 3% (ϪE); P Ͻ 0.05 nRCA vs. SVG-RCA], which was attenuated by a nonspecific endothelin and a specific endothelin receptor A antagonist. Thus coronary aspirate from stented nRCA is characterized by less debris but more endothelin and stronger vasoconstrictor response than that from SVG-RCA. coronary disease; ischemia; native coronary artery; saphenous vein graft; vasoconstriction INTERVENTIONAL PLAQUE RUPTURE induces the release of not only particulate debris but also soluble vasoconstrictor, thrombogenic, and inflammatory substances from the lesion that all contribute to impair microvascular coronary perfusion. Typical consequences of coronary microvascular obstruction are microinfarcts with subsequent inflammation, arrhythmias, contractile dysfunction, and impaired coronary flow reserve (14). Various protection devices have been used to capture and remove the released plaque material. A prognostic benefit from distal protection devices in elective interventions has been established only for saphenous vein grafts (SVGs) (3, 39), whereas a benefit for native coronary arteries still remains to be demonstrated (14) .
INTERVENTIONAL PLAQUE RUPTURE induces the release of not only particulate debris but also soluble vasoconstrictor, thrombogenic, and inflammatory substances from the lesion that all contribute to impair microvascular coronary perfusion. Typical consequences of coronary microvascular obstruction are microinfarcts with subsequent inflammation, arrhythmias, contractile dysfunction, and impaired coronary flow reserve (14) . Various protection devices have been used to capture and remove the released plaque material. A prognostic benefit from distal protection devices in elective interventions has been established only for saphenous vein grafts (SVGs) (3, 39) , whereas a benefit for native coronary arteries still remains to be demonstrated (14) .
The underlying atherosclerosis in native coronary arteries differs from that in SVGs, which is more rapidly progressing (28, 34) . Upon stent implantation, native vessels release less and smaller particulate debris than SVGs (9, 12) . However, the histological composition of the released particulate debris from native vessels and SVGs during elective and acute interventions does not differ (12) . The vasoconstrictor endothelin is released into native coronary arteries during acute coronary syndromes (1) . In contrast, endothelin is not released into SVGs during elective stent implantation (16) .
The aspirate retrieved during stent implantation under protection with a distal occlusion/aspiration device might serve as a biological offprint of the culprit lesion (19) . We have therefore now compared intravascular ultrasound (IVUS) imaging before with quantification of the released particulate debris after stent implantation, including its calcium content, as well as determined soluble vasoconstrictors (catecholamines, endothelin, serotonin, thromboxane, and tissue factor) and an inflammatory mediator [TNF␣ as a prototype of inflammatory cytokines (11, 18) ] in the aspirate from stented native right coronary arteries (nRCA) versus that from SVGs on right coronary arteries (SVG-RCA). We compared the aspirateinduced vasoconstrictor potential of nRCA versus SVG-RCA using a rat mesenteric artery bioassay. From the analysis of particulate debris and soluble factors in nRCA versus SVGs, the potential for microvascular obstruction can be estimated; such data do not exist so far.
MATERIALS AND METHODS
Study cohort. Symptomatic, male patients with stable angina pectoris and with a flow-limiting stenosis in their nRCA (n ϭ 18) or SVG-RCA (n ϭ 18) were enrolled in an exploratory study without a precise hypothesis and an according power calculation. The study was conducted in accordance with the ethical guidelines of the Declaration of Helsinki 1975, approved by the Institutional Review Board (GZ.: 07-3387) and registered at ClinicalTrials.gov (NCT01430884). All patients gave their informed consent.
Quantitative coronary angiography. All patients were on oral aspirin (100 mg/day). Fifteen patients in each group were also on oral clopidogrel (75 mg/day) before the intervention, for indications such as prior stent implantation or acute coronary syndromes within a year before the current study. After additional loading with clopidogrel (600 mg oral) and heparin (10.000 IU iv) coronary angiography was performed using the femoral approach and 6-Fr or 8-Fr guiding catheters. Stenosis severity was quantified using off-line caliper measurements (QCA-MEDIS, Leiden, The Netherlands) (13) , and thrombolysis in myocardial infarction (TIMI) flow was measured before and after stent implantation (41).
IVUS and virtual histology. IVUS was performed before and after stent implantation with a commercial catheter (20 MHz, Eagle-Eye, Volcano, Rancho Cordova, CA) and pullback device (0.5 mm/s, R-100, Volcano). The site and length of the target lesion were retrospectively identified after stent implantation from landmarks in the vascular profile (2, 27) . Plaque composition was categorized with virtual histology (VH) using customized software (pcVHTM2.1, Volcano). Plaque components (fibrotic, fibro-fatty, necrotic core, dense calcium) were presented as a fraction of total plaque volume (%) (2) .
Interventional procedure. The implantation of balloon-expandable bare metal stents was performed with direct stenting without prior dilatation/debulking and a stent diameter-to-vessel diameter ratio of 1:1.15, because stenting with prior dilatation increases plaque mobilization and debris embolism (20) . To prevent microembolization, a distal balloon occlusion/aspiration device (GuardWire Temporary Occlusion & Aspiration System; Medtronic, Minneapolis, MN) (22) was used. Before stent implantation, the balloon of the device was inflated at 2-4 atm with contrast agent. After stent implantation, the balloon catheter was removed and the aspiration catheter loaded on the wire balloon. During slow withdrawal of this catheter, the blood column was retrieved. The distal wire balloon was then deflated.
Coronary arterial blood and aspirate. Coronary arterial blood was taken through the aspiration catheter (10 ml into heparin-S-monovette, Sarstedt, Nümbrecht, Germany) distal to the lesion before the stent implantation and served as a control. Coronary aspirate (between 10 and 20 ml) was filtered ex vivo through a 40-m mesh filter. The aspirate dilution by contrast agent was corrected for by reference to the hematocrit. Visible particulate debris was retained on the filter and weighed. The weight of the released debris was normalized to stent volume. The filtered coronary arterial and aspirate samples were immediately centrifuged (800 g, 10 min, 4°C). Both particulate debris and plasma samples were quickly frozen in liquid nitrogen and stored at Ϫ80°C until further use.
Morphology of particulate debris. Particulate debris was stained according to Pappenheim using May-Grünwald and Giemsa solutions (Merck, Darmstadt, Germany). A fraction of the particulate debris was spread out on a glass plate and allowed to dry. May-Grünwald solution was incubated for 3 min after addition of water (3 min) and rinsing with water, Giemsa solution (diluted, 20 drops to 10 ml water) was incubated for 15 min. After being rinsed with water, stained particulate debris was again dried. The stained debris was visualized at 200-fold magnification using light microscopy (Leika DM LB, Characteristics of patients with stenotic native right coronary arteries (nRCA) and saphenous vein graft on right coronary arteries (SVG-RCA) and their lesions, respectively. Continuous data are presented as means Ϯ SE; categorical data, as absolute numbers. Comparison between patients with nRCA and with SVG-RCA by unpaired t-test (continuous data) and 2-tailed Fisher exact test (categorical data).ACE, angiotensin-converting enzyme; AT1, angiotensin II type 1; CAD, coronary artery disease; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MLA, minimal lumen cross-sectional area in the culprit segment; MLD, minimal lumen diameter; RLA, reference lumen area; RVD, reference vessel diameter. Wetzlar, Germany) in 10 preparations from nRCA and SVG aspirates each.
Calcium, vasoconstrictors, tissue factor, tumor necrosis factor-␣, and troponin I. The calcium concentration (sum of ionized and bound/complexed calcium) was measured in particulate debris and coronary arterial and aspirate plasma after extraction with HCl by atomic absorption spectrophotometry (2) . Endothelin, serotonin, thromboxane (Tx)B 2, tissue factor and TNF␣ concentrations in particulate debris, coronary arterial and aspirate plasma were determined using enzyme immunometric assay kits (Cayman Chemical, Ann Arbor, MI, for endothelin, TNF␣ and TxB 2; Assay Designs for serotonin; American Diagnostica, for tissue factor). Epinephrine and norepinephrine in coronary arterial and aspirate plasma were determined by HPLC with electrochemical detection (EC 41.000 Chromsystems, München, Germany) using a kit and a reverse-phase analytical column (Chromsystems, München, Germany) (2). Peripheral venous blood was taken before and between 6 and 48 h after stent implantation to determine serum troponin I (2, 17). Serum troponin I was measured using a specific two-side immunoassay detected with the Dimension RxL Max Integrated System (Dimension Flex, Dade Behring GmbH, Marburg; and Siemens, Eschborn, Germany).
Vasomotor bioassay. Human coronary arteries and rat mesenteric arteries are characterized by a comparable receptor arrangement for serotonin and TxA 2 (4, 7, 31, 32) . Therefore, we used rat mesenteric arteries with intact and denuded endothelium (ϩE/ϪE) as a bioassay. Segments of 2 mm length were mounted in a Mulvany myograph and equilibrated with Krebs-Henseleit buffer. After verification of functionality in response to acetylcholine, vessels were incubated with coronary arterial and aspirate plasma, which was diluted to a final ratio of 1:10 vol/vol (after correction for dilution by the hematocrit) (2, 17) . In a subset of experiments, we compared the vasoconstrictor response of the rat mesenteric arteries with intact endothelium to aspirate plasma from nRCA and SVG-RCA after dilution to a final ratio of 1:10 and 1:20 vol/vol (n ϭ 4, each). Constrictor responses were recorded over 8 min and normalized to the maximum vasoconstriction induced by 120 mmol/l KCl (%KCl max ϭ 100%) (2, 17) . In a subset of experiments, the contribution of endothelin to the vasoconstriction by nRCA coronary aspirate plasma was determined using the nonspecific endothelin receptor antagonist PD-142893 (10 Ϫ6 mol/ l), the specific endothelin receptor type A (ETA) receptor antagonist BQ-123 (10 Ϫ6 mol/l), the specific endothelin receptor type B (ETB) receptor antagonist BQ-788 (10 Ϫ6 mol/l), and the endothelin-converting enzyme inhibitor phosphoramidon (10 Ϫ5 mol/l; 30 min preincubation, respectively) (24, 26) . In control experiments, the efficacy of the receptor antagonists and the converting enzyme inhibitor was verified: BQ-123 prevented the endothelin (10 Ϫ7 mol/l)-induced vasoconstriction but left the endothelin-induced vasodilation intact (1 Ϯ 1 vs. of 113 Ϯ 15% of KCl max; n ϭ 4), and BQ-788 attenuated the endothelin-induced vasodilation in the presence of BQ-123 (10 Ϯ 2 vs. 1 Ϯ 1% of KCl max; n ϭ 4). Phosphoramidon inhibited the vasoconstriction induced by big endothelin (10 Ϫ7 mol/l) (1 Ϯ 1 vs. 20 Ϯ 5% of KClmax; n ϭ 3).
Endothelium-dependent dilator responses of coronary arterial plasma or coronary aspirate plasma from nRCA-and SVG-RCApreconstricted mesenteric arteries to cumulatively increasing concentrations of acetylcholine (10 Ϫ9 to 10 Ϫ4 mol/l) were determined (n ϭ 6, each). Dilator responses were expressed as percentage of the maximal preconstriction.
Statistical analysis. Continuous data are presented as means Ϯ SE, categorical as absolute numbers. Patient characteristics were compared using unpaired t-test (continuous data) and 2-tailed Fisher's exact test (categorical data). Serum troponin I and TIMI flow grading before and after stent implantation and mediator concentrations in and vasoconstrictor responses to coronary arterial and aspirate plasma were compared between patients with a stenosis in their nRCA or SVG-RCA using two-way repeated-measures ANOVA, followed by Bonferroni's post hoc tests. The statistic tests were done with SPSS Statistics 19.0 (SPSS, Chicago, IL). Least-square sigmoidal curve fitting of concentration-response curves was done with Origin 7GRS2 (Northampton, MA), and concentration-response curves were compared by two-way repeated-measures ANOVA to assess differences between the groups. Statistics were performed with SPSS Statistics 19.0 (SPSS). P Ͻ 0.05 was considered significant.
RESULTS
Patient characteristics with stenotic nRCA and SVG-RCA were comparable apart from their target vessel, reference lumen area, and stent diameter (Table 1) . In both groups, TIMI flow was higher after stent implantation but not different between groups (Table 2 ). Serum troponin I was increased after stent implantation and also not different between groups (Table 2) . However, the increase in troponin I after stent implantation was modest and exceeded the proposed cutoff level of 0.15 g/l, reflecting myonecrosis (40) , in only seven patients with stenotic nRCA and nine patients with SVG-RCA.
Volume and composition of plaques and particulate debris. Plaque volume and composition were comparable between patients with a stenotic nRCA and a SVG-RCA (Fig. 1) . The amount of released particulate debris from nRCA was less than that from SVG-RCA, even when normalized to stent volume, respectively. Examples of Pappenheim-stained particular debris from nRCA and SVG-RCA are presented in Fig. 1 . There were typical foam cells, platelet aggregates, and adhering leukocytes. In 10 samples each, the composition of particulate material from nRCA and SVG-RCA did not differ. Confirming the IVUS VH analysis, the calcium concentration in particulate debris was not different between nRCA and SVG-RCA (Fig. 1) .
Calcium, vasoconstrictors, tissue factor, and TNF␣ concentrations in and vasomotor response to coronary aspirate.
The concentration of calcium in coronary aspirate plasma was 2.4 Ϯ 0.2 mmol/l in patients with a stenotic nRCA and 2.6 Ϯ 0.2 mmol/l in those with a stenotic SVG-RCA, respectively. The concentrations of vasoconstrictors, tissue factor, and TNF␣ in particulate debris were not different between nRCA and SVG-RCA (Table 3) . Also, the concentrations of epinephrine, norepinephrine, and tissue factor in coronary aspirate plasma were not different between nRCA and SVG-RCA and not altered by stent implantation. Serotonin, TxB 2 , and TNF␣ concentrations in coronary aspirate plasma were increased after stent implantation, but not different between nRCA and SVG-RCA. In contrast, the endothelin concentration was increased after stent implantation only in the coronary aspirate plasma of patients with a stenotic nRCA, but not of those with a stenotic SVG-RCA (Table 4) . As expected from the released soluble substances, the coronary aspirate plasma from patients with a stenotic nRCA induced stronger vasoconstriction than that of patients with a stenotic SVG-RCA, and more so in the Concentrations of vasoconstrictors, tissue factor, and TNF␣ in particulate debris, released during stent implantation. Data are means Ϯ SE; n ϭ 10/10, each.TNF␣, tumor necrosis factor-␣. absence than the presence of endothelium (Fig. 2) . The ex vivo vasoconstrictor response was concentration dependent for coronary aspirate plasma from nRCA and SVG-RCA: The force of contraction induced by a 1:10 dilution was 88 Ϯ 8 and 58 Ϯ 6 and that by 1:20 dilution 40 Ϯ 4 and 26 Ϯ 4% KCl max , respectively. A nonspecific endothelin receptor antagonist and a specific ET A antagonist attenuated the vasoconstriction induced by aspirate plasma taken from nRCA in the presence and absence of endothelium, whereas a specific ET B antagonist or an endothelin-converting enzyme inhibitor did not affect the nRCA aspirate-induced vasoconstriction ( Fig. 2; n ϭ 6, each) .
Acetylcholine induced a concentration-dependent vasodilation that was more potently attenuated by coronary aspirate plasma from nRCA than SVG-RCA (Fig. 3) .
DISCUSSION
For the comparison of the potential for microvascular obstruction by release of particulate debris and/or soluble substances from native coronary arteries versus SVGs during stent implantation, we have studied a small cohort of patients undergoing elective stent implantation for a stenosis in their nRCA or SVG-RCA, respectively. We detected the same plaque volume and the same plaque composition, confirming prior reports in patients with stable and unstable angina (37) . The ex vivo measurement of calcium, endothelin, serotonin, TxB 2 , tissue factor, and TNF␣ in particulate debris confirmed the comparable plaque composition by IVUS VH. Despite of the comparable plaque volume and composition, we found less particulate debris in coronary aspirate from nRCA than from SVG-RCA, again confirming prior studies (9, 12) . Apparently, when compared with native coronary arteries, the thinner medial layer of the SVGs predisposes them to mechanical damage during interventional plaque rupture and to release of more particulate debris (35) .
In both nRCA and SVG-RCA, we found no release of catecholamines and tissue factor into the aspirate, again confirming our prior reports (2, 16). The small, but not significant, increase of catecholamines probably reflects the stress situation during percutaneous coronary intervention. In patients with acute coronary syndromes, a release of tissue factor into the aspirate has been reported (6) . In line with our current and prior results, it appears that the release of tissue factor is attributed to thrombotic processes and not to the underlying atherosclerotic substrate and therefore only seen during acute coronary syndromes, but not during elective interventions.
We detected a release of the soluble mediators serotonin, TxB 2 , and TNF␣ into the aspirate of nRCA and SVG-RCA, confirming our prior studies in SVG lesions (2, 16, 21) . However, the release of these mediators was comparable between nRCA and SVG-RCA. All our patients were treated with platelet activation inhibitors. Clopidogrel decreases the release of serotonin, but there remains a residual and interindividually different release (29) . Such release of serotonin is attributed to platelet activation during stent implantation, despite dual platelet inhibition with aspirin and clopidogrel (5, 15) . Aspirin inactivates platelet TxA 2 synthesis. The release of TxA 2 in the presence of aspirin and clopidogrel is attributed to macrophages and other nucleated cells in the atherosclerotic vascular wall which rapidly recover from the aspirin-induced irreversible inhibition of cyclooxygenase-2 activity through de novo synthesis in response to inflammatory and mitogenic stimuli (8, 10, 33) . Also, we cannot exclude an insufficient suppression of platelet TxA 2 (25) . The release of TNF␣ is attributed to inflammatory cells in the atherosclerotic vascular wall (23) . In contrast to serotonin, TxA 2 , and TNF␣, the release of endothelin during stent implantation was greater in coronary aspirate plasma from nRCA than from SVG-RCA; however, the concentration of endothelin in the particulate debris did not differ. Endothelin is a potent vasoconstrictor peptide and predominantly synthesized in endothelial cells, but also in leukocytes, macrophages, vascular smooth muscle cells, and cardiomyocytes (24, 38) . Plaques retrieved during acute coronary syndromes are enriched with endothelin (1, 30, 42) . Our current data during elective intervention and in the absence of thrombosis attribute the increased endothelin release from nRCA to the vascular wall, but not to the atherosclerotic lesion, since the endothelin concentration in particulate debris did not differ between nRCA and SVG-RCA. Therefore, the greater endothelin release from nRCA most likely originates from the thicker vascular smooth muscle cell layer of native vessels. A regional, neointimal smooth muscle cell and atherosclerotic lesion-specific higher activity of the endothelin system has been reported in patients at early stages after percutaneous coronary intervention (36) . In line with the increased endothelin release, coronary aspirate from nRCA induced a stronger, vasoconstrictor response ex vivo than that from SVG-RCA. Since nonspecific and specific endothelin receptor A blockade attenuated the vasoconstriction to aspirate from nRCA to the same magnitude, ET A receptors apparently mediate the vasoconstrictor effects of endothelin, whereas the dilation mediating ET B receptors play no major role (24) . An endothelin-converting enzyme inhibitor did not affect the nRCA aspirate-induced vasoconstriction. Apparently, the observed vasoconstriction was a direct response to the released endothelin and not to a substance that stimulated the release of endothelin. We were unable to analyze the effects of the different composition of coronary aspirate form nRCA and SVG-RCAs on microvascular obstruction, as, by definition, we removed debris and soluble substances; accordingly, postinterventional troponin release was modest. The postinterventional troponin increase tended to be greater following nRCA interventions, possibly reflecting a spillover despite aspiration and spotty microvascular ischemia in response to endothelin.
Our study supports the use of protection devices to capture particulate debris and soluble substances released after stent implantation into SVGs. Given that so far no evidence for the use of protection devices has been obtained for stent implantation into native coronary arteries, the greater release of endothelin appears not to be of major importance for the clinical outcome. Nevertheless, our observational study highlights potential differences between different vascular segments when undergoing stent implantation and provides a mechanistic background for potential pharmacological antagonism of microvascular obstruction in case aspiration is not used.
Study limitations. Our study is limited to a small number of patients undergoing elective percutaneous coronary intervention of their nRCA and SVG-RCA and requires prospective confirmation in larger cohorts. The texture and size of both vessel types and the underlying process of atherosclerosis are quite different. IVUS VH has not been validated for use in SVGs, and the lack of a clear interface between media and adventitia in SVG makes vessel volume, including plaque volume, measurements more problematic than in native coronary arteries (2) . We focussed on the release of vasoconstrictors rather than vasodilators, because the overall response to aspirate was a strong vasoconstriction.
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